MA40496A - Capsacinoïdes et leurs utilisations en tant que médicaments - Google Patents

Capsacinoïdes et leurs utilisations en tant que médicaments

Info

Publication number
MA40496A
MA40496A MA040496A MA40496A MA40496A MA 40496 A MA40496 A MA 40496A MA 040496 A MA040496 A MA 040496A MA 40496 A MA40496 A MA 40496A MA 40496 A MA40496 A MA 40496A
Authority
MA
Morocco
Prior art keywords
capsaicinoids
medicaments
medicament
treatment
capsaicinoid
Prior art date
Application number
MA040496A
Other languages
English (en)
Inventor
Mandishora Israel Muzari
Original Assignee
Mandishora Israel Muzari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014903253A external-priority patent/AU2014903253A0/en
Application filed by Mandishora Israel Muzari filed Critical Mandishora Israel Muzari
Publication of MA40496A publication Critical patent/MA40496A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un médicament contenant un capsacinoïde, possédant une activité antivirale et utile dans le traitement d'infections virales et dans le traitement du vih/sida. Le médicament présente également une activité d'amélioration de la neuroplasticité et est utile dans le traitement du stress et d'autres conditions psychologiques. De plus, le médicament possède une activité anti-inflammatoire et est utile dans le traitement de l'arthrite. Le médicament a aussi montré qu'il possède une
MA040496A 2014-08-19 2015-07-31 Capsacinoïdes et leurs utilisations en tant que médicaments MA40496A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2014903253A AU2014903253A0 (en) 2014-08-19 Viral therapy

Publications (1)

Publication Number Publication Date
MA40496A true MA40496A (fr) 2017-06-28

Family

ID=55349992

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040496A MA40496A (fr) 2014-08-19 2015-07-31 Capsacinoïdes et leurs utilisations en tant que médicaments

Country Status (8)

Country Link
US (1) US20170239198A1 (fr)
EP (1) EP3182968A4 (fr)
KR (1) KR20170066344A (fr)
AU (1) AU2015306063A1 (fr)
CA (1) CA2961766A1 (fr)
EA (1) EA201700114A1 (fr)
MA (1) MA40496A (fr)
WO (1) WO2016025977A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ752750A (en) 2016-11-02 2023-05-26 Centrexion Therapeutics Corp Stable aqueous capsaicin injectable formulations and medical uses thereof
ES3018268T3 (en) 2017-07-20 2025-05-14 Centrexion Therapeutics Corp Compositions and their use for treatment of pain using capsaicin
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) * 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US20030082249A1 (en) * 2001-10-26 2003-05-01 Ovation Pharmaceuticals Compositions containing capsaicin and its derivatives, and their use in treating mucositis
FR2849992B1 (fr) * 2003-01-17 2007-03-16 Inst Phytoceutic Composition pour une administration par voie orale contenant des capsaicinoides
US20040224037A1 (en) * 2003-04-28 2004-11-11 Gonzalo Romero-Matos Devastating treatment against hiv/aids with capsaicin

Also Published As

Publication number Publication date
KR20170066344A (ko) 2017-06-14
EP3182968A4 (fr) 2018-05-09
AU2015306063A1 (en) 2017-04-13
EP3182968A1 (fr) 2017-06-28
EA201700114A1 (ru) 2017-06-30
CA2961766A1 (fr) 2016-02-25
WO2016025977A1 (fr) 2016-02-25
US20170239198A1 (en) 2017-08-24

Similar Documents

Publication Publication Date Title
MX2020005187A (es) Compuestos y composiciones farmaceuticas antivirales, asi como metodos de uso de los mismos.
ZA201708692B (en) Antibacterial compounds
ZA201708236B (en) Methods and compositions for rna-guided treatment of hiv infection
IL246117A0 (en) Administration, use and therapeutic applications of crispr-cas systems and preparations for HBV and viral diseases and disorders
SI3019499T1 (sl) Policiklične karbamoilpiridonske spojine in njihova uporaba za zdravljenje HIV infekcij
IL258459A (en) Therapeutic compositions for treatment of human immunodeficiency virus
IL263368A (en) Prevention and treatment of viral infections
NZ738524A (en) Pharmaceutical formulations comprising rilpivirine hydrochloride, tenofovir alafenamide hemifumarate, and emtricitabine
PL3413897T3 (pl) Sposoby leczenia i profilaktyki HIV i AIDS
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
MX395492B (es) Usos terapeuticos de l-4 cloroquinurenina.
EP3534961C0 (fr) Formulations injectables aqueuses stables de capsaïcine et leurs utilisations médicales
MA40496A (fr) Capsacinoïdes et leurs utilisations en tant que médicaments
IN2014MU00916A (fr)
SG11201602501VA (en) Hiv treatment formulation of atazanavir and cobicistat
MX2016002560A (es) Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
PH12015502564B1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
EA201890653A1 (ru) Композиция с противовирусным эффектом
SG11202011775VA (en) Antiviral treatment of flavivirus infection
EP3091990A4 (fr) Traitement du virus de l'immunodéficience humaine/du syndrome de l'immunodéficience acquise
GB201615035D0 (en) Treatment and prevention of viral infection
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
PL3095866T3 (pl) Środek do profilaktyki i terapii infekcji wirusowych
SG10202010317VA (en) Pyrimidine prodrugs for the treatment of viral infections and further diseases
ES1136284Y (es) Conjunto modular de mesa y sillas